Methods and compositions for the sustained release of chromium
Provided herein are compositions for the administration of chromium that include at least two components: a hydrophilic chromium complex and a lipophilic chromium complex, and methods of using the same. Also provided are compositions for the administration of chromium that include a first “fast-acting” chromium complex and a second “slow-acting” chromium complex, wherein the first chromium complex is absorbed more quickly than the slow-acting chromium complex, and methods of using the same. Also provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising a fast-acting chromium complex and a slow-acting chromium complex, to the individual.
1. A composition comprising:
a first amount of chromium histidinate; and
a second amount of chromium picolinate;
wherein the first and second amounts have a molar ratio of chromium between 1:10 and 10:1.
2. The composition of claim 1 , wherein the first amount and second amounts have a molar ratio of chromium between 1:8 and 8:1.
3. The composition of claim 1 , wherein the first amount and second amounts have a molar ratio of chromium between 1:4 and 4:1.
4. The composition of claim 1 , wherein the first amount and second amounts have a molar ratio of chromium between 1:2 and 2:1.
5. The composition of claim 1 , wherein the first amount and second amounts have a molar ratio of chromium of about 1:1.
6. The composition of claim 1 , wherein first amount of chromium histidinate is selected from the group consisting of chromium and histidine, a chromium histidinate complex, and combinations thereof.
7. The composition of claim 1 , wherein first amount of chromium histidinate consists essentially of a chromium histidinate complex.